81,95 €
81,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
41 °P sammeln
81,95 €
81,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
41 °P sammeln
Als Download kaufen
81,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
41 °P sammeln
Jetzt verschenken
81,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
41 °P sammeln
  • Format: PDF

Regenerative medicine is at a pivotal point. Innovations in the science and the rapid growth of translational medicine are transforming the field just as institutional arrangements are changing, making this an exciting yet unsettled time. Recent court cases and policy initiatives are creating crosscurrents that keep older issues from being settled while introducing new dilemmas. Current research propels collaborations across disciplines and sectors, raising the question of how tensions between the protection of intellectual property and the movement toward 'open science' can be negotiated.…mehr

Produktbeschreibung
Regenerative medicine is at a pivotal point. Innovations in the science and the rapid growth of translational medicine are transforming the field just as institutional arrangements are changing, making this an exciting yet unsettled time. Recent court cases and policy initiatives are creating crosscurrents that keep older issues from being settled while introducing new dilemmas. Current research propels collaborations across disciplines and sectors, raising the question of how tensions between the protection of intellectual property and the movement toward 'open science' can be negotiated. Other important social, ethical and legal questions arise in the gray areas created by new scientific techniques and pragmatic areas involved in scale-up and testing in humans. The times call for governance that is adaptive to meet the needs of science yet able to maintain public trust.

The contributors address these and other vital questions through chapters focusing on topics such as data sharing; patenting of human biological material; and managing collaborations across academic, industry and government sectors as well as across national boundaries. Key research ethics issues are also included such as obtaining consent from biospecimen donors; accessing biorepository data, and considerations in designing preclinical and clinical trial protocols for first-in-human research, including upcoming policy changes.

Rather than retracing well-trodden topics, the book points to nascent areas that need to be addressed. Whether working in academia, industry, or government, regenerative medicine scientists and managers need to know how to navigate current and upcoming issues of governance facing the field. Regenerative Medicine Ethics:Governing Research and Knowledge Practices will be a valuable resource for scientists, policy-makers and students as they plan and execute responsible research.

About the Editor

Linda F. Hogle is Professor of Medical Social Sciences in the School of Medicine & Public Health at the University of Wisconsin-Madison and Fellow at the Wisconsin Institutes for Discovery. Her research includes analyses of social, ethical, and legal issues in emerging cell-based and biomedical engineering technologies, as well as concepts of risk in innovative science as understood by governance bodies. She has served as an advisor to several international research consortia focusing on stem cell and regenerative medicine.


Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
Linda F. Hogle is Professor of Medical Social Sciences in the School of Medicine & Public Health at the University of Wisconsin-Madison and Fellow at the Wisconsin Institutes for Discovery.  Her research includes analyses of social, ethical, and legal issues in emerging cell-based and biomedical engineering technologies, as well as concepts of risk in innovative science as understood by governance bodies. She has served as an advisor to several international research consortia focusing on stem cell and regenerative medicine. Contributors include: Sean P. Palecek, University of Wisconsin-Madison, Department of Chemical and Biological Engineering, WI David Schaffer, University of California-Berkeley, Department of Chemical and Biomolecular Engineering, CA Peter W. Zandstra, University of Toronto, Institute of Biomaterials and Biomedical Engineering, ON, Canada David B. Resnik, National Institute of Environmental Health Sciences, NC Tania Bubela, University of Alberta, Department of Public Health Sciences, AB, Canada Amrita Mishra, University of Alberta, Department of Public Health Sciences, AB, Canada Debra J. H. Mathews, The Johns Hopkins University, Berman Institute of Bioethics, MD Kevin E. Noonan, McDonnell Boehnen Hulbert & Berghoff LLP, IL Pilar N. Ossorio, University of Wisconsin-Madison Law School, WI Jessica von Reyn, University of Wisconsin-Madison Law School, WI Nancy M. P. King, Wake Forest University School of Medicine, Department of Social Sciences and Health Policy, NC Amritava Das, University of Wisconsin-Madison, Department of Chemical and Biological Engineering, WI
Rezensionen
From the book reviews:
"The book will appeal to ethicists and college professors who are interested in research ethics and/or ethical, legal, and social implications (ELSI) projects. The book also will be useful to a variety of students interested in law and bioethics, or who are planning to conduct RMR. ... this book provides many interesting insights into RMR, and those in the intended audience likely will find it to be useful, relevant, and thought provoking." (Joseph T. Norris, Doody's Book Reviews, September, 2014)